Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nyaditum resae in TB Contacts
NCT02897180Phase 3Unknown
- Sponsor
- Germans Trias i Pujol Research Institute
- Start
- Mar 2017
- Primary completion
- Oct 2020
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Nyaditum resae in Tuberculosis (TB), sponsored by Germans Trias i Pujol Research Institute. Status: unknown.
02
Drugs
Nyaditum resae
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02897180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897180.